Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;51(7):857-66.
doi: 10.1007/s11745-016-4161-x. Epub 2016 May 24.

Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma

Affiliations

Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma

Christa L Montgomery et al. Lipids. 2016 Jul.

Abstract

Neurons are especially susceptible to oxidative damage, which is increasingly implicated in neurodegenerative disease. Certain N-acylethanolamines (NAEs) have been shown to protect neurons from oxidative stress. Since glaucoma may be considered a neurodegenerative disorder and the survival of retinal neurons could also be influenced by N-acylethanolamines, our goal was to quantify changes in certain N-acylethanolamine species and their oxylipin derivatives in the retina of a mouse model for glaucoma. We also sought to identify relationships between these and parameters of glaucoma disease development, specifically intraocular pressure, visual acuity, and contrast sensitivity. Five N-acylethanolamine species and three NAE oxylipin derivatives were quantified in retina from young and aged DBA/2Crl mice. N-Acylethanolamines and NAE-oxylipins in retinal extracts were quantified against deuterated standards by isotope dilution gas chromatography-mass spectrometry. Levels (nmol/g dry weight) of N-arachidonoylethanolamine (anandamide; NAE 20:4) were significantly (p = 0.008) decreased in aged (2.875 ± 0.6702) compared to young animals (5.175 ± 0.971). Conversely, the anandamide oxylipin, 15(S)-HETE ethanolamide (15(S)-HETE EA), was significantly (p = 0.042) increased in aged (0.063 ± 0.009) compared to young animals (0.039 ± 0.011). Enzymatic depletion of the anandamide pool by 15-lipoxygenase and consequent accumulation of 15(S)-HETE ethanolamine may contribute to decreased visual function in glaucomatous mice. Since N-acylethanolamines effectively attenuate glaucoma pathogenesis and associated visual impairment, our data provides additional rationale and novel targets for glaucoma therapies.

Keywords: Acylethanolamides; Anandamide; Contrast sensitivity; DBA/2; Intraocular pressure; Lipoxin; Lipoxygenase; N-Linoleoylethanolamine; N-Oleylethanolamine; Neuroprotection; Optokinetic reflex; Optomotor; Visual acuity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Intraocular pressure increases and visual function decreases in aged DBA/2Crl mice. a Aged (~9 m; n = 18 eyes) DBA/2Crl mice demonstrate significantly (P = 0.0022) elevated intraocular pressure (IOP) compared to young (7 w; n = 20 eyes) controls. b, c Aged mice have a significant (n = 20 eyes; p < 0.0001) deficit in visual acuity (VA) and contrast sensitivity (CS) compared to young controls. d IOP correlates moderately with visual function. e CS and VA correlate strongly with each other. Data are expressed as mean ± SD. IOP measurements are symbolized with triangles, VA with circles, and CS with squares. Open symbols represent young eyes and closed symbols aged eyes. Dashed lines represent the 95 % confidence interval
Fig. 2
Fig. 2
Increased 16:0, 18:0, 18:2, and 20:4 N-acylethanolamine levels in the DBA/2Crl retina correlate with lower intraocular pressure and better visual function. a NAE 16:0 levels correlate moderately with visual acuity (VA) and intraocular pressure (IOP), but not significantly. There is a strong correlation that approaches statistical significance between NAE 16:0 and contrast sensitivity (CS). b NAE 18:0 levels correlate moderately with VA and CS, but not significantly. There is a strong, statistically significant correlation between NAE 18:0 and IOP. c NAE 18:1 levels do not correlate with VA, CS, or IOP. d NAE 18:2 levels correlate moderately with VA, but not significantly. There is a strong correlation that approaches statistical significance between NAE 18:2 and CS. A statistically significant, strong correlation is seen between NAE 18:2 and IOP. e NAE 20:4 levels correlate strongly and significantly with both VA and CS. There is a moderate correlation between NAE 20:4 and IOP that is not statistically significant. f Table of statistical values from correlations ae. Data are expressed as mean ± SD. IOP measurements are symbolized with triangles, VA with circles, and CS with squares. Open symbols represent young eyes and closed symbols aged eyes. Dashed lines represent the 95 % confidence interval
Fig. 3
Fig. 3
Increased levels of the N-acylethanolamine oxylipins 9NAE-HOD and 15(S)-HETE EA correlate with higher intraocular pressure and declining visual function. a 9NAE-HOD levels correlate moderately with intraocular pressure (IOP) and weakly with visual acuity (VA) and contrast sensitivity (CS), but not significantly. b 13NAE-HOD levels do not correlate with VA, CS, or IOP. c 15(S)-HETE EA levels correlate weakly with IOP, but not significantly. There is a strong correlation that approaches statistical significance between 15(S)-HETE EA and CS. A statistically significant, strong correlation is seen between 15(S)-HETE EA and VA. d Table of statistical values from correlations ac. Data are expressed as mean ± SD. IOP measurements are symbolized with triangles, VA with circles, and CS with squares. Open symbols represent young eyes and closed symbols aged eyes. Dashed lines represent the 95 % confidence interval

Similar articles

Cited by

References

    1. Terland O, Flatmark T, Tangeras A, Gronberg M. Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species. J Mol Cell Cardiol. 1997;29(6):1731–1738. - PubMed
    1. Floyd RA, Towner RA, He T, Hensley K, Maples KR. Translational research involving oxidative stress and diseases of aging. Free Radic Biol Med. 2011;51(5):931–941. - PMC - PubMed
    1. Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med. 2004;10(Suppl):S18–S25. - PubMed
    1. Ohia SE, Opere CA, Leday AM. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res. 2005;579(1–2):22–36. - PubMed
    1. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238–242. - PMC - PubMed

Publication types